Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A critical review of the reproductive safety of Leflunomide.

Clinical rheumatology·2019
Same author

The new biologics in pregnancy.

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique·2014
Same author

Safety of tacrolimus in pregnancy.

Canadian family physician Medecin de famille canadien·2014
Same author

Safety of the newer class of opioid antagonists in pregnancy.

Canadian family physician Medecin de famille canadien·2014
Same author

Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.

Arthritis & rheumatology (Hoboken, N.J.)·2014
Same author

Tdap vaccination during pregnancy to reduce pertussis infection in young infants.

Canadian family physician Medecin de famille canadien·2013

Related Experiment Video

Updated: May 10, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Update on antidepressant use during breastfeeding.

Lauren Chad, Anna Pupco, Pina Bozzo

    Canadian Family Physician Medecin De Famille Canadien
    |June 15, 2013
    PubMed
    Summary

    Newer antidepressants are safe for breastfeeding mothers with postpartum depression. These medications transfer in low amounts to breast milk without serious adverse events, allowing mothers to choose the most effective treatment.

    Area of Science:

    • Perinatology
    • Pharmacology
    • Neonatal Medicine

    Background:

    • Postpartum depression (PPD) affects many mothers.
    • Mothers with PPD often desire to continue breastfeeding.
    • Concerns exist regarding the safety of antidepressant medications during lactation.

    Purpose of the Study:

    • To evaluate the safety of newer antidepressant medications for infants exposed through breast milk.
    • To provide guidance for clinicians treating breastfeeding mothers with PPD.

    Main Methods:

    • Review of current literature on newer antidepressant pharmacokinetics and infant outcomes during breastfeeding.
    • Analysis of reported adverse events associated with antidepressant use in lactating women.

    Main Results:

    Related Experiment Videos

    Last Updated: May 10, 2026

    Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
    08:15

    Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

    Published on: June 6, 2025

    • Newer antidepressants are excreted in low concentrations in human breast milk.
    • No serious adverse events have been consistently reported in breastfed infants exposed to these medications.
    • Infant exposure levels are generally considered safe.

    Conclusions:

    • Newer antidepressants appear to be a safe option for breastfeeding mothers with PPD.
    • The benefits of treating maternal depression and enabling continued breastfeeding outweigh potential risks.
    • Treatment decisions should prioritize the most effective antidepressant for the mother's well-being.